The lysophosphatidic acid receptor LPA 1 promotes epithelial cell apoptosis after lung injury

American Journal of Respiratory Cell and Molecular Biology

Volumn 46, Issue 3, 2012, Pages 355-364

  Funke, Manuela ^a   Zhao, Zhenwen ^b   Xu, Yan ^b   Chun, Jerold ^c   Tager, Andrew M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Epithelial cells, lysophosphatidic acid; LPA 1; Pulmonary fibrosis

Indexed keywords

BLEOMYCIN; CASPASE 3; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHATIDIC ACID RECEPTOR; LYSOPHOSPHATIDIC ACID RECEPTOR 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOIKIS; APOPTOSIS; ARTICLE; BRONCHUS MUCOSA; CELL ANCHORAGE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO CULTURE; LUNG ALVEOLUS EPITHELIUM; LUNG FIBROBLAST; LUNG INJURY; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION;

ANIMALS; ANOIKIS; APOPTOSIS; BLEOMYCIN; CASPASE 3; CELL ADHESION; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; LUNG; LUNG INJURY; LYSOPHOSPHOLIPIDS; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; PULMONARY FIBROSIS; RATS; RECEPTORS, LYSOPHOSPHATIDIC ACID; SIGNAL TRANSDUCTION; TIME FACTORS;

MUS; RATTUS;

EID: 84863296032     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2010-0155OC     Document Type: Article

References (50)

1. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151. (Pubitemid 32096342)
2. Tager AM, LaCamera P, Shea BS, Campanella GS, Selman M, Zhao Z, Polosukhin V, Wain J, Karimi-Shah BA, Kim ND, et al. The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak. Nat Med 2008;14:45-54.
3. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, Lin ME, Teo ST, Park KE, Mosley AN, et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 2010;50:157-186.
4. Ye X, Ishii I, KingsburyMA, Chun J. Lysophosphatidic acid as a novel cell survival/apoptotic factor. Biochim Biophys Acta 2002;1585:108-113. (Pubitemid 36092074)
5. Kuwano K, Kunitake R, Kawasaki M, Nomoto Y, Hagimoto N, Nakanishi Y, Hara N. P21Waf1/Cip1/Sdi1 and p53 expression in association with DNA strand breaks in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1996;154:477-483. (Pubitemid 26269122)
6. Plataki M, Koutsopoulos AV, Darivianaki K, Delides G, Siafakas NM, Bouros D. Expression of apoptotic and antiapoptotic markers in epithelial cells in idiopathic pulmonary fibrosis. Chest 2005;127: 266-274. (Pubitemid 41724587)
7. Hagimoto N, Kuwano K, Miyazaki H, Kunitake R, Fujita M, Kawasaki M, Kaneko Y, Hara N. Induction of apoptosis and pulmonary fibrosis in mice in response to ligation of Fas antigen. Am J Respir Cell Mol Biol 1997;17:272-278. (Pubitemid 127500830)
8. Matute-Bello G, Wurfel MM, Lee JS, Park DR, Frevert CW, Madtes DK, Shapiro SD, Martin TR. Essential role of MMP-12 in Fasinduced lung fibrosis. Am J Respir Cell Mol Biol 2007;37:210-221. (Pubitemid 47255004)
9. Lee CG, Cho SJ, Kang MJ, Chapoval SP, Lee PJ, Noble PW, Yehualaeshet T, Lu B, Flavell RA, Milbrandt J, et al. Early growth response gene 1- mediated apoptosis is essential for transforming growth factor beta1- induced pulmonary fibrosis. J Exp Med 2004;200:377-389. (Pubitemid 39031256)
10. Sisson TH, Mendez M, Choi K, Subbotina N, Courey A, Cunningham A, Dave A, Engelhardt JF, Liu X, White ES, et al. Targeted injury of type II alveolar epithelial cells induces pulmonary fibrosis. Am J Respir Crit Care Med 2010;181:254-263.
11. Hagimoto N, Kuwano K, Nomoto Y, Kunitake R, Hara N. Apoptosis and expression of Fas/Fas ligand mRNA in bleomycin-induced pulmonary fibrosis in mice. Am J Respir Cell Mol Biol 1997;16:91-101. (Pubitemid 127497440)
12. Chang W, Wei K, Jacobs SS, Upadhyay D, Weill D, Rosen GD. SPARC suppresses apoptosis of idiopathic pulmonary fibrosis fibroblasts through constitutive activation of beta-catenin. J Biol Chem 2010;285:8196-8206.
13. Funke M, Shea BS, Groom J, Castelino F, Brooks SF, Chun J, Tager AM. Lysophosphatidic acid contributes to an apoptosis paradox in lung fibrosis [abstract]. Am J Respir Crit Care Med 2009;:A1988.
14. Contos JJ, Fukushima N, Weiner JA, Kaushal D, Chun J. Requirement for the LPA1 lysophosphatidic acid receptor gene in normal suckling behavior. Proc Natl Acad Sci USA 2000;97:13384-13389.
15. Xiao YJ, Schwartz B, Washington M, Kennedy A, Webster K, Belinson J, Xu Y. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids: comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids. Anal Biochem 2001;290:302-313. (Pubitemid 32217542)
16. Knebel JW, Aufderheide M, Emura M. Comparison of biological effects of different polycyclic aromatic hydrocarbons in lung cells of hamster and rat in vitro. Toxicol Lett 1994;72:65-72. (Pubitemid 24180214)
17. Koslowski R, Barth K, Augstein A, Tschernig T, Bargsten G, Aufderheide M, Kasper M. A new rat type I-like alveolar epithelial cell line R3/1: bleomycin effects on caveolin expression. Histochem Cell Biol 2004;121:509-519. (Pubitemid 38916439)
18. Tager AM, Kradin RL, LaCamera P, Bercury SD, Campanella GS, Leary CP, Polosukhin V, Zhao LH, Sakamoto H, Blackwell TS, et al. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. Am J Respir Cell Mol Biol 2004;31:395-404. (Pubitemid 39330949)
19. Kuwano K, Hagimoto N, Tanaka T, Kawasaki M, Kunitake R, Miyazaki H, Kaneko Y, Matsuba T, Maeyama T, Hara N. Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. J Pathol 2000;190:221-229. (Pubitemid 30082497)
20. Kuwano K, Kunitake R, Maeyama T, Hagimoto N, Kawasaki M, Matsuba T, Yoshimi M, Inoshima I, Yoshida K, Hara N. Attenuation of bleomycin-induced pneumopathy in mice by a caspase inhibitor. Am J Physiol Lung Cell Mol Physiol 2001;280:L316-L325.
21. Dobbs LG, Williams MC, Gonzalez R. Monoclonal antibodies specific to apical surfaces of rat alveolar type I cells bind to surfaces of cultured, but not freshly isolated, type II cells. Biochim Biophys Acta 1988;970:146-156.
22. Savani RC, Godinez RI, Godinez MH, Wentz E, Zaman A, Cui Z, Pooler PM, Guttentag SH, Beers MF, Gonzales LW, et al. Respiratory distress after intratracheal bleomycin: selective deficiency of surfactant proteins B and C. Am J Physiol Lung Cell Mol Physiol 2001;281:L685-L696.
23. Zhao Z, Xu Y. Measurement of endogenous lysophosphatidic acid by ESI-MS/MS in plasma samples requires pre-separation of lysophosphatidylcholine. J Chromatogr B Analyt Technol Biomed Life Sci 2009;877:3739-3742.
24. Moore A, Donahue CJ, Bauer KD, Mather JP. Simultaneous measurement of cell cycle and apoptotic cell death. Methods Cell Biol 1998;57: 265-278. (Pubitemid 128787445)
25. Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA 2006;103:13180-13185. (Pubitemid 44338936)
26. Ramsey WS, Hertl W, Nowlan ED, Binkowski NJ. Surface treatments and cell attachment. In Vitro 1984;20:802-808. (Pubitemid 15171902)
27. Medoff BD, Landry AL, Wittbold KA, Sandall BP, Derby MC, Cao Z, Adams JC, Xavier RJ. CARMA3 mediates lysophosphatidic acidstimulated cytokine secretion by bronchial epithelial cells. Am J Respir Cell Mol Biol 2009;40:286-294.
28. Castelino FV, Seiders J, Bain G, Brooks SF, King C, Swaney JS, Lorrain DS, Chun J, Luster AD, Tager AM. Genetic deletion or pharmacologic antagonism of LPA(1) ameliorates dermal fibrosis in a scleroderma mouse model. Arthritis Rheum 2011;63:1405-1415.
29. Swaney JS, Chapman C, Correa LD, Stebbins KJ, Broadhead AR, Bain G, Santini AM, Darlington J, King CD, Baccei C, et al. Pharmacokinetic and pharmacodynamic characterization of an oral, LPA1-selective antagonist. J Pharmacol Exp Ther 2011;336:693-700.
30. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 1994;124:619-626. (Pubitemid 24064472)
31. Gilmore AP. Anoikis. Cell Death Differ 2005;12:1473-1477. (Pubitemid 41553981)
32. Gilmore AP, Owens TW, Foster FM, Lindsay J. How adhesion signals reach a mitochondrial conclusion-ECM regulation of apoptosis. Curr Opin Cell Biol 2009;21:654-661.
33. Cheng TL, Symons M, Jou TS. Regulation of anoikis by Cdc42 and Rac1. Exp Cell Res 2004;295:497-511. (Pubitemid 38490502)
34. Fang X, Yu S, LaPushin R, Lu Y, Furui T, Penn LZ, Stokoe D, Erickson JR, Bast RC Jr, Mills GB. Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogenactivated protein kinase. Biochem J 2000;352:135-143.
35. Ohta H, Sato K, Murata N, Damirin A, Malchinkhuu E, Kon J, Kimura T, Tobo M, Yamazaki Y, Watanabe T, et al. Ki16425, a subtypeselective antagonist for EDG-family lysophosphatidic acid receptors. Mol Pharmacol 2003;64:994-1005. (Pubitemid 37153068)
36. Thannickal VJ, Horowitz JC. Evolving concepts of apoptosis in idiopathic pulmonary fibrosis. Proc Am Thorac Soc 2006;3:350-356. (Pubitemid 43845412)
37. Chiarugi P, Giannoni E. Anoikis: A necessary death program for anchorage- dependent cells. Biochem Pharmacol 2008;76:1352-1364.
38. Makino H, Sugiyama H, Kashihara N. Apoptosis and extracellular matrixcell interactions in kidney disease. Kidney Int Suppl 2000;77:S67-S75.
39. Mooney A, Jackson K, Bacon R, Streuli C, Edwards G, Bassuk J, Savill J. Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals. Am J Pathol 1999;155:599-606. (Pubitemid 29370409)
40. Furui T, LaPushin R, Mao M, Khan H, Watt SR, Watt MA, Lu Y, Fang X, Tsutsui S, Siddik ZH, et al. Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner. Clin Cancer Res 1999;5:4308-4318. (Pubitemid 30013820)
41. Weiner JA, Chun J. Schwann cell survival mediated by the signaling phospholipid lysophosphatidic acid. Proc Natl Acad Sci USA 1999;96: 5233-5238. (Pubitemid 29214566)
42. Weiner JA, Fukushima N, Contos JJ, Scherer SS, Chun J. Regulation of schwann cell morphology and adhesion by receptor-mediated lysophosphatidic acid signaling. J Neurosci 2001;21:7069-7078. (Pubitemid 32846954)
43. Rahimi RA, Leof EB. TGF-beta signaling: a tale of two responses. J Cell Biochem 2007;102:593-608. (Pubitemid 47557414)
44. Hagimoto N, Kuwano K, Inoshima I, Yoshimi M, Nakamura N, Fujita M, Maeyama T, Hara N. TGF-beta 1 as an enhancer of Fas-mediated apoptosis of lung epithelial cells. J Immunol 2002;168:6470-6478. (Pubitemid 34620072)
45. Solovyan VT, Keski-Oja J. Proteolytic activation of latent TGF-beta precedes caspase-3 activation and enhances apoptotic death of lung epithelial cells. J Cell Physiol 2006;207:445-453.
46. Zhang HY, Phan SH. Inhibition of myofibroblast apoptosis by transforming growth factor beta(1). Am J Respir Cell Mol Biol 1999;21:658-665. (Pubitemid 129502284)
47. Horowitz JC, Rogers DS, Sharma V, Vittal R, White ES, Cui Z, Thannickal VJ. Combinatorial activation of Fak and Akt by transforming growth factor-beta1 confers an anoikis-resistant phenotype to myofibroblasts. Cell Signal 2007;19:761-771. (Pubitemid 46290691)
48. Maher TM, Evans IC, Bottoms SE, Mercer PF, Thorley AJ, Nicholson AG, Laurent GJ, Tetley TD, Chambers RC, McAnulty RJ. Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010;182:73-82.
49. Coker RK, Laurent GJ, Jeffery PK, du Bois RM, Black CM, McAnulty RJ. Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax 2001; 56:549-556. (Pubitemid 32588534)
50. Borok Z, Gillissen A, Buhl R, Hoyt RF, Hubbard RC, Ozaki T, Rennard SI, Crystal RG. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am Rev Respir Dis 1991;144:1080-1084.